Welcome to CoronaBlog – a coronavirus blog from CompBioMed that updates you with what’s happening in the fight against coronovirus, using supercomputers.
- CompBioMed Associate Partners predicting the impact of closing your local shop on the spread of covid-19
Researchers from the Brunel University have developed a simulation tool that models the viral spread at the sub-national level, the “Flu And Corona virus Simulator” (FACS). FACS incorporates geospatial data from open sources to single building resolution within small predefined regions. Using FACS, the researchers have modelled the spread of Covid-19 at the local level…Read More+
Read More » - The World’s Fastest Computer to Join Fight Against COVID-19
In our previous blog posts we have highlighted in the work of the Argonne National Laboratory (ANL) and Barcelona Supercomputing Center (BSC) that High Performance Computing (HPC) resources are an invaluable research tool. Much like their counterparts and colleagues around the world, Japan’s top scientists are now refocusing and accelerating their research efforts towards addressing…Read More+
Read More » - AI-driven integrative biology for accelerating therapeutic drug discoveries to treat SARS-CoV-2
CompBioMed partners and academics from other research facilities are carrying out research to address the fundamental biological mechanisms of both the SARS-CoV-2 novel corona virus and the COVID-19 disease it causes. The ongoing research also includes an attempt to target the entire viral proteome (entire complement of proteins that is or can be expressed by…Read More+
Read More » - Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart
The use of certain drugs can disturb the rhythm at which hearts beat. This disruption can have toxic effects on the heart, which are particularly dangerous for those with underlying medical conditions. Two drugs which are known to have proarrhythmic effects are the antimalarial drugs azithromycin and hydroxychloroquine. Azithromycin and hydroxychloroquine are thought to be…Read More+
Read More » - Repurposing Existing Drugs in the Fight Against COVID-19
The use of existing pharmaceutical to treat COVID-19 has several potential benefits over the development of new drugs from the group up, not least that much shorter clinical trials would be needed and production on industrial scales has already been realised in many cases. Andrew Potterton, a PhD student at UCL and Evotec, described to…Read More+
Read More »
CompBioMed-Coronavirus Pages:
CompBioMed and Coronavirus
The Consortium on Coronavirus
CompBioMed Partner Activity
Call for Contributions
Coronavirus Research Resources
Coronavirus Blog
Areas of Research:
Computational Drug Discovery
Epitope Analysis
Drug Toxicity
Computational Epidemiology
Virus Evolutionary Analysis
Host Response Analysis